PDE4A and fragile X syndrome: Together, the studies by Kanellopoulos et al. and Choi et al. highlight the link between mGluR hyperactivity and cAMP signaling deficits in FXS and validate PDE4 inhibition as a promising therapeutic approach to ameliorate cognitive and synaptic dysfunction in individuals with FXS [32,33].